• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定临床细菌分离株的西他沙星流行病学临界值(ECOFFs)。

Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial Isolates.

作者信息

Zhang Jingjia, Li Xue, Jia Xinmiao, Li Yun, Zheng Bo, Yu Yunsong, Hu Fupin, Sun Ziyong, Chen Zhongju, Zhang Ge, Kang Wei, Wang Tong, Li Jin, Gao Haotian, Yi Qiaolian, Yu Wei, Chu Xiaobing, Xu Yingchun, Yang Qiwen

机构信息

Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

Clinical Biobank, Biomedical Engineering Facility of National Infrastructures for Translational Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, Peoples Republic of China.

出版信息

Infect Drug Resist. 2025 Apr 23;18:1993-2004. doi: 10.2147/IDR.S501783. eCollection 2025.

DOI:10.2147/IDR.S501783
PMID:40290404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12034273/
Abstract

OBJECTIVE

To establish the epidemiological cut-off values (ECOFFs) of sitafloxacin against , and

METHODS

We collected 2264 clinical isolates from five different labs located in four cities in China. The minimum inhibitory concentrations (MICs) and inhibition zone diameters of sitafloxacin for all isolates were determined by using the broth microdilution method (BMD) and the disk diffusion method according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. MIC ECOFFs were determined using ECOFFinder software, with the 99% calculated ECOFF selected as the initial value. Zone diameter ECOFFs were determined via the visual estimation method. Whole-genome sequencing was performed on strains exhibiting overlapping MICs between wild-type (WT) and non-wild-type (NWT) groups to analyze resistance mechanisms.

RESULTS

Sitafloxacin MICs ranged from 0.002 to 64 mg/L, while inhibition zone diameters ranged from 6 to 45 mm across the nine species. MIC ECOFFs were determined as 0.032, 0.064, 0.125, 0.5, 0.064, 0.125, 0.5, 0.25, and 0.125 mg/L for (tentative ECOFF), , and , respectively. Except for , MICs of the other eight species showed a high correlation with zone diameters (|r| > 0.8, P < 0.0001). Consequently, the zone diameter ECOFFs were established as 26, 25, 24, 24, 25, 26, 21, and 22 for , and , respectively.

CONCLUSION

We established MIC and zone diameter ECOFFs for sitafloxacin against the nine species listed above. The MIC ECOFF for was classified as tentative. For , the correlation between zone diameters and MICs was insufficient to establish a zone diameter ECOFF.

摘要

目的

确定西他沙星对[具体菌种]的流行病学截断值(ECOFFs)。

方法

我们从中国四个城市的五个不同实验室收集了2264株临床分离株。根据欧洲抗菌药物敏感性试验委员会(EUCAST)指南,采用肉汤微量稀释法(BMD)和纸片扩散法测定了所有分离株对西他沙星的最低抑菌浓度(MICs)和抑菌圈直径。使用ECOFFinder软件确定MIC ECOFFs,选择计算出的99% ECOFF作为初始值。通过视觉估计法确定抑菌圈直径ECOFFs。对野生型(WT)和非野生型(NWT)组之间MIC重叠的菌株进行全基因组测序,以分析耐药机制。

结果

西他沙星的MIC范围为0.002至64 mg/L,九个菌种的抑菌圈直径范围为6至45 mm。[具体菌种1]、[具体菌种2]等的MIC ECOFFs分别确定为0.032、0.064、0.125、0.5、0.064、0.125、0.5、0.25和0.125 mg/L(暂定ECOFF)。除[具体菌种X]外,其他八个菌种的MIC与抑菌圈直径高度相关(|r|>0.8,P<0.0001)。因此,[具体菌种1]、[具体菌种2]等的抑菌圈直径ECOFFs分别确定为26、25、24、24、25、26、21和22。

结论

我们确定了西他沙星对上述九个菌种的MIC和抑菌圈直径ECOFFs。[具体菌种X]的MIC ECOFF分类为暂定。对于[具体菌种Y],抑菌圈直径与MIC之间的相关性不足以确定抑菌圈直径ECOFF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/b2071d2c2791/IDR-18-1993-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/f5537d54c95a/IDR-18-1993-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/e2f329753463/IDR-18-1993-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/58ca6638f028/IDR-18-1993-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/b2071d2c2791/IDR-18-1993-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/f5537d54c95a/IDR-18-1993-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/e2f329753463/IDR-18-1993-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/58ca6638f028/IDR-18-1993-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604c/12034273/b2071d2c2791/IDR-18-1993-g0004.jpg

相似文献

1
Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial Isolates.确定临床细菌分离株的西他沙星流行病学临界值(ECOFFs)。
Infect Drug Resist. 2025 Apr 23;18:1993-2004. doi: 10.2147/IDR.S501783. eCollection 2025.
2
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa.建立新型四代头孢菌素头孢噻利对大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌、奇异变形杆菌和铜绿假单胞菌的流行病学折点值。
J Antimicrob Chemother. 2021 Sep 15;76(10):2593-2599. doi: 10.1093/jac/dkab216.
3
Establishment of epidemiological cut-off values of etimicin: a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Acinetobacter baumannii and Staphylococcus aureus.依替米星针对大肠埃希菌、肺炎克雷伯菌、奇异变形杆菌、铜绿假单胞菌、鲍曼不动杆菌和金黄色葡萄球菌的流行病学截断值的确定:一种新型第四代氨基糖苷类抗生素
J Antimicrob Chemother. 2025 Feb 3;80(2):381-385. doi: 10.1093/jac/dkae414.
4
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis.测定金黄色葡萄球菌、表皮葡萄球菌、溶血葡萄球菌和人葡萄球菌中甲砜霉素的流行病学折点(ECOFFs)。
J Antimicrob Chemother. 2021 Jan 1;76(1):152-159. doi: 10.1093/jac/dkaa414.
5
European multi-centre study to establish MIC and zone diameter epidemiological cut-off values for Bacillusanthracis.欧洲多中心研究建立炭疽芽孢杆菌 MIC 和抑菌环直径的流行病学折点值。
Clin Microbiol Infect. 2024 Sep;30(9):1170-1175. doi: 10.1016/j.cmi.2024.05.019. Epub 2024 Jun 7.
6
Setting of the tentative epidemiological cut-off values of contezolid for Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Streptococcus pneumoniae and Streptococcus agalactiae.确定康替唑胺对金黄色葡萄球菌、粪肠球菌、屎肠球菌、肺炎链球菌和无乳链球菌的暂定流行病学临界值。
J Antimicrob Chemother. 2023 Apr 3;78(4):1055-1058. doi: 10.1093/jac/dkad045.
7
Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values.伯克霍尔德菌多中心研究以确定欧洲抗菌药物敏感性试验委员会(EUCAST)的最低抑菌浓度(MIC)和抑菌圈直径分布以及流行病学临界值。
Clin Microbiol Infect. 2020 Jul 9. doi: 10.1016/j.cmi.2020.07.001.
8
Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus.建立依拉环素对大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌、鲍曼不动杆菌和金黄色葡萄球菌的流行病学折点值。
J Antimicrob Chemother. 2024 Sep 3;79(9):2246-2250. doi: 10.1093/jac/dkae220.
9
In vitro susceptibility test of sitafloxacin against resistant gram-negative bacilli isolated from Thai patients by disk diffusion method.采用纸片扩散法对从泰国患者中分离出的耐甲氧西林革兰阴性杆菌进行西他沙星的体外药敏试验。
J Med Assoc Thai. 2014 Mar;97 Suppl 3:S7-12.
10
In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.司他夫沙星及其他抗生素对诗琳通公主殿下医学中心、泰国先皇技术学院和三美泰素坤逸医院分离出的细菌的体外活性
J Med Assoc Thai. 2017 Apr;100(4):469-78.

本文引用的文献

1
Antibacterial Mechanisms and Clinical Impact of Sitafloxacin.司帕沙星的抗菌机制及临床影响
Pharmaceuticals (Basel). 2024 Nov 16;17(11):1537. doi: 10.3390/ph17111537.
2
Novel Penicillin Derivatives Against Selected Multiple-drug Resistant Bacterial Strains: Design, Synthesis, Structural Analysis, and Studies.新型青霉素衍生物对选定的多重耐药菌的抑制作用:设计、合成、结构分析及研究
Curr Org Synth. 2024;21(5):684-703. doi: 10.2174/1570179420666230510104319.
3
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
迈向非结核分枝杆菌临床折点 - 使用肉汤微量稀释法测定鸟分枝杆菌复合群和脓肿分枝杆菌的流行病学切点值。
Clin Microbiol Infect. 2023 Jun;29(6):758-764. doi: 10.1016/j.cmi.2023.02.007. Epub 2023 Feb 20.
4
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model.在动态体外尿路感染模型中,西他沙星对多重耐药菌的药代动力学/药效学研究
J Antimicrob Chemother. 2022 Dec 23;78(1):141-149. doi: 10.1093/jac/dkac365.
5
Epidemiological cut-off value and antibiotic susceptibility test methods for azithromycin in a collection of multi-country invasive non-typhoidal Salmonella.多国侵袭性非伤寒沙门氏菌中阿奇霉素的流行病学截断值和抗生素药敏试验方法。
Clin Microbiol Infect. 2022 Dec;28(12):1615-1623. doi: 10.1016/j.cmi.2022.06.009. Epub 2022 Jun 20.
6
Sitafloxacin Expresses Potent Anti- Activity.西他沙星具有强大的抗活性。
Front Microbiol. 2022 Jan 6;12:779531. doi: 10.3389/fmicb.2021.779531. eCollection 2021.
7
The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.经直肠前列腺活检男性的直肠拭子分离出的肠杆菌科中氟喹诺酮耐药的分子机制:靶向预防的原理。
Ann Clin Microbiol Antimicrob. 2021 Dec 7;20(1):81. doi: 10.1186/s12941-021-00487-y.
8
Sitafloxacin for Third-Line Eradication: A Systematic Review.西他沙星用于三线根除治疗:一项系统评价
J Clin Med. 2021 Jun 20;10(12):2722. doi: 10.3390/jcm10122722.
9
A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia.一项评价口服司帕沙星对比莫西沙星治疗成人社区获得性肺炎的有效性和安全性的随机、对照、多中心临床试验。
Curr Med Res Opin. 2021 Apr;37(4):693-701. doi: 10.1080/03007995.2021.1885362. Epub 2021 Feb 22.
10
A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection.一项随机、阳性对照、多中心临床试验,旨在评估口服司帕沙星与左氧氟沙星在中国成年急性单纯性或复杂性尿路感染患者中的疗效和安全性。
Ann Med. 2021 Dec;53(1):217-226. doi: 10.1080/07853890.2020.1861322.